{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:58:16Z","timestamp":1792979896988,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-12206-5","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T16:47:09Z","timestamp":1767026829000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and safety of letermovir for cytomegalovirus prophylaxis in thoracic organ transplantation: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Abdullah Yousef","family":"Aldalati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayham Mohammad","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khald","family":"Aldalati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bara M.","family":"Hammadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassel","family":"Alrabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Al-dabagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moath","family":"Albliwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Abuassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badi","family":"Rawashdeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"12206_CR1","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.2147\/IDR.S180908","volume":"12","author":"G El Helou","year":"2019","unstructured":"El Helou G, Razonable RR. Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review. Infect Drug Resist. 2019;12:1481\u201391.","journal-title":"Infect Drug Resist"},{"issue":"4","key":"12206_CR2","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1097\/TP.0000000000004855","volume":"108","author":"AG Stewart","year":"2024","unstructured":"Stewart AG, Kotton CN. What\u2019s new: updates on cytomegalovirus in solid organ transplantation. Transplantation. 2024;108(4):884\u201397.","journal-title":"Transplantation"},{"issue":"8","key":"12206_CR3","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1097\/TP.0000000000004615","volume":"107","author":"KB Blom","year":"2023","unstructured":"Blom KB, Birkeland GK, Midtvedt K, Jenssen TG, Reis\u00e6ter AV, Rollag H, et al. Cytomegalovirus High-risk kidney transplant recipients show no difference in Long-term outcomes following preemptive versus prophylactic management. Transplantation. 2023;107(8):1846\u201353.","journal-title":"Transplantation"},{"issue":"25","key":"12206_CR4","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","volume":"377","author":"FM Marty","year":"2017","unstructured":"Marty FM, Ljungman P, Chemaly RF, Maertens J, Dadwal SS, Duarte RF, et al. Letermovir prophylaxis for cytomegalovirus in Hematopoietic-Cell transplantation. N Engl J Med. 2017;377(25):2433\u201344.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"12206_CR5","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1093\/infdis\/jiz454","volume":"221","author":"G Haidar","year":"2020","unstructured":"Haidar G, Boeckh M, Singh N. Cytomegalovirus infection in solid organ and hematopoietic cell transplantation: state of the evidence. J Infect Dis. 2020;221(Suppl 1):S23\u201331.","journal-title":"J Infect Dis"},{"issue":"6","key":"12206_CR6","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/TP.0000000000002191","volume":"102","author":"CN Kotton","year":"2018","unstructured":"Kotton CN, Kumar D, Caliendo AM, Huprikar S, Chou S, Danziger-Isakov L, et al. The third international consensus guidelines on the management of cytomegalovirus in Solid-organ transplantation. Transplantation. 2018;102(6):900\u201331.","journal-title":"Transplantation"},{"issue":"9","key":"12206_CR7","doi-asserted-by":"publisher","first-page":"e13512","DOI":"10.1111\/ctr.13512","volume":"33","author":"RR Razonable","year":"2019","unstructured":"Razonable RR, Humar A. Cytomegalovirus in solid organ transplant recipients-Guidelines of the American society of transplantation infectious diseases community of practice. Clin Transplant. 2019;33(9):e13512.","journal-title":"Clin Transplant"},{"key":"12206_CR8","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. 2021;372:n71.","DOI":"10.1136\/bmj.n71"},{"issue":"9","key":"12206_CR9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135.","journal-title":"Eur J Epidemiol"},{"issue":"10","key":"12206_CR10","first-page":"2127","volume":"18","author":"Z Munn","year":"2020","unstructured":"Munn Z, Barker TH, Moola S, Tufanaru C, Stern C, McArthur A, et al. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synthesis. 2020;18(10):2127\u201333.","journal-title":"JBI Evid Synthesis"},{"key":"12206_CR11","doi-asserted-by":"crossref","unstructured":"Singha A, Burcham PK, Logan A, El Boghdadly Z, Howsare MM, Nunley DR, et al. Letermovir for cytomegalovirus prophylaxis in lung transplant patients with valganciclovir-induced leukopenia. 2021;2(2):129\u201339.","DOI":"10.3390\/transplantology2020013"},{"key":"12206_CR12","doi-asserted-by":"crossref","unstructured":"Saltiel G, Faure E, Assaf A, Chopin M-C, Moreau F, Faure K, et al. Real-life use of letermovir prophylaxis for cytomegalovirus in heart transplant recipients. 2024;38(5):e15327.","DOI":"10.1111\/ctr.15327"},{"key":"12206_CR13","doi-asserted-by":"crossref","unstructured":"Tran N, Tossey J, Fallah T. Crushing obstacles: a case series on alternative letermovir administration in transplant recipients. Am J Health-Syst Pharm. 2024.","DOI":"10.1093\/ajhp\/zxae307"},{"key":"12206_CR14","doi-asserted-by":"crossref","unstructured":"Martinez S, Sindu D, Nailor MD, Cherrier L, Tokman S, Walia R, et al. Evaluating the efficacy and safety of letermovir compared to valganciclovir for the prevention of human cytomegalovirus disease in adult lung transplant recipients. 2024;26(3):e14279.","DOI":"10.1111\/tid.14279"},{"key":"12206_CR15","doi-asserted-by":"crossref","unstructured":"Kleiboeker HL, Wang J, Borkowski N, Miner B, Prom A, Paplaczyk K, et al. Use of letermovir for cytomegalovirus primary prophylaxis in lung transplant recipients. 2024;26(5):e14337.","DOI":"10.1111\/tid.14337"},{"key":"12206_CR16","doi-asserted-by":"crossref","unstructured":"Kleiboeker HL, Prom A, Paplaczyk K, Wang J, Borkowski N, Miner B, et al. Impact of letermovir for cytomegalovirus primary prophylaxis on myelosuppression and immunosuppression in lung transplant recipients. 2024;38(12):e70033.","DOI":"10.1111\/ctr.70033"},{"issue":"1","key":"12206_CR17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s10238-024-01330-2","volume":"24","author":"T Hirama","year":"2024","unstructured":"Hirama T, Shundo Y, Watanabe T, Ohsumi A, Watanabe T, Okada Y. Letermovir prophylaxis for cytomegalovirus in lung-transplant recipients: a comprehensive study with literature review of off-label use and real-world experiences. Clin Experimental Med. 2024;24(1):68.","journal-title":"Clin Experimental Med"},{"key":"12206_CR18","doi-asserted-by":"crossref","unstructured":"Golob S, Batra J, DeFilippis EM, Uriel M, Carey M, Gaine M, et al. Letermovir for cytomegalovirus prophylaxis in high-risk heart transplant recipients. 2022;36(12):e14808.","DOI":"10.1111\/ctr.14808"},{"key":"12206_CR19","doi-asserted-by":"crossref","unstructured":"Aryal S, Katugaha SB, Cochrane A, Brown AW, Nathan SD, Shlobin OA, et al. Single-center experience with use of letermovir for CMV prophylaxis or treatment in thoracic organ transplant recipients. 2019;21(6):e13166.","DOI":"10.1111\/tid.13166"},{"key":"12206_CR20","doi-asserted-by":"crossref","unstructured":"Mezochow AK, He KD, Whitaker K, Blumberg E, Crespo MM, Courtwright A. Letermovir use for cytomegalovirus prophylaxis following lung transplantation: a single-center review. JHLT Open. 2024;6.","DOI":"10.1016\/j.jhlto.2024.100149"},{"issue":"4","key":"12206_CR21","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.healun.2021.12.005","volume":"41","author":"JL Saullo","year":"2022","unstructured":"Saullo JL, Baker AW, Snyder LD, Reynolds JM, Zaffiri L, Eichenberger EM, et al. Cytomegalovirus prevention in thoracic organ transplantation: A single-center evaluation of letermovir prophylaxis. J Heart Lung Transplantation: Official Publication Int Soc Heart Transplantation. 2022;41(4):508\u201315.","journal-title":"J Heart Lung Transplantation: Official Publication Int Soc Heart Transplantation"},{"key":"12206_CR22","doi-asserted-by":"crossref","unstructured":"Paya C, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. 2004;4(4):611\u201320.","DOI":"10.1111\/j.1600-6143.2004.00382.x"},{"key":"12206_CR23","doi-asserted-by":"crossref","unstructured":"Matsumoto K, Shigemi A, Ikawa K, Kanazawa N, Fujisaki Y, Morikawa N, et al. Risk factors for ganciclovir-induced thrombocytopenia and leukopenia. 2015;38(2):235\u20138.","DOI":"10.1248\/bpb.b14-00588"},{"key":"12206_CR24","doi-asserted-by":"crossref","unstructured":"Belga S, Hernandez C, Kabbani D, Cervera CJTID. Incidence of valganciclovir-related leukopenia and neutropenia in solid organ transplant recipients at high risk of cytomegalovirus disease. 2024;26(2):e14227.","DOI":"10.1111\/tid.14227"},{"issue":"9","key":"12206_CR25","first-page":"2356","volume":"76","author":"A-G M\u00e4rtson","year":"2021","unstructured":"M\u00e4rtson A-G, Edwina AE, Burgerhof JG, Berger SP, de Joode A, Damman K, et al. Ganciclovir Therapeutic Drug Monit Transpl Recipients. 2021;76(9):2356\u201363.","journal-title":"Ganciclovir Therapeutic Drug Monit Transpl Recipients"},{"key":"12206_CR26","doi-asserted-by":"publisher","unstructured":"Aldalati AY, Hussein AM, Balbaa E, Hammadeh BM, Idrees M, Aloudat O, Albliwi M, Abuassi M, Sultan I. Efficacy and safety of letermovir for cytomegalovirus prophylaxis in pediatric hematopoietic stem cell transplantation recipients: a systematic review, meta-analysis, and meta-regression. Transpl Infect Dis. 2025;27(2):e70006. https:\/\/doi.org\/10.1111\/tid.70006.","DOI":"10.1111\/tid.70006"},{"issue":"1","key":"12206_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/jama.2023.9106","volume":"330","author":"AP Limaye","year":"2023","unstructured":"Limaye AP, Budde K, Humar A, Vincenti F, Kuypers DRJ, Carroll RP, et al. Letermovir vs valganciclovir for prophylaxis of cytomegalovirus in High-Risk kidney transplant recipients: A randomized clinical trial. JAMA. 2023;330(1):33\u201342.","journal-title":"JAMA"},{"issue":"4","key":"12206_CR28","doi-asserted-by":"publisher","first-page":"e13570","DOI":"10.1111\/tid.13570","volume":"23","author":"RJ Winstead","year":"2021","unstructured":"Winstead RJ, Kumar D, Brown A, Yakubu I, Song C, Thacker L, et al. Letermovir prophylaxis in solid organ transplant-Assessing CMV breakthrough and tacrolimus drug interaction. Transpl Infect Disease: Official J Transplantation Soc. 2021;23(4):e13570.","journal-title":"Transpl Infect Disease: Official J Transplantation Soc"},{"issue":"3","key":"12206_CR29","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/ctr.12686","volume":"30","author":"E Beam","year":"2016","unstructured":"Beam E, Lesnick T, Kremers W, Kennedy CC, Razonable RR. Cytomegalovirus disease is associated with higher all-cause mortality after lung transplantation despite extended antiviral prophylaxis. Clin Transplant. 2016;30(3):270\u20138.","journal-title":"Clin Transplant"},{"issue":"12","key":"12206_CR30","doi-asserted-by":"publisher","first-page":"e15142","DOI":"10.1111\/ctr.15142","volume":"37","author":"MR Jorgenson","year":"2023","unstructured":"Jorgenson MR, Descourouez JL, Saddler CM, Smith JA, Odorico JS, Rice JP, et al. Real world experience with conversion from valganciclovir to letermovir for cytomegalovirus prophylaxis: letermovir reverses leukopenia and avoids mycophenolate dose reduction. Clin Transplant. 2023;37(12):e15142.","journal-title":"Clin Transplant"},{"issue":"6","key":"12206_CR31","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/QCO.0000000000000965","volume":"36","author":"DD Wong","year":"2023","unstructured":"Wong DD, Ho SA, Domazetovska A, Yong MK, Rawlinson WD. Evidence supporting the use of therapeutic drug monitoring of ganciclovir in transplantation. Curr Opin Infect Dis. 2023;36(6):505\u201313.","journal-title":"Curr Opin Infect Dis"},{"issue":"10","key":"12206_CR32","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/jcph.1423","volume":"59","author":"JB McCrea","year":"2019","unstructured":"McCrea JB, Macha S, Adedoyin A, Marshall W, Menzel K, Cho CR, et al. Pharmacokinetic Drug-Drug interactions between letermovir and the immunosuppressants Cyclosporine, Tacrolimus, Sirolimus, and mycophenolate mofetil. J Clin Pharmacol. 2019;59(10):1331\u20139.","journal-title":"J Clin Pharmacol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12206-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12206-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12206-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T16:47:11Z","timestamp":1767026831000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12206-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12206"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12206-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"13 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1766"}}